Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Capital Employed (2016 - 2025)

United Therapeutics' Return on Capital Employed history spans 16 years, with the latest figure at 0.21% for Q4 2025.

  • For Q4 2025, Return on Capital Employed changed 0.0% year-over-year to 0.21%; the TTM value through Dec 2025 reached 0.21%, changed 0.0%, while the annual FY2025 figure was 0.21%, 0.0% changed from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.21% at United Therapeutics, roughly flat from 0.21% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.22% in Q2 2024 and bottomed at 0.08% in Q1 2021.
  • The 5-year median for Return on Capital Employed is 0.18% (2022), against an average of 0.18%.
  • The largest annual shift saw Return on Capital Employed fell -9bps in 2021 before it grew 10bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 0.12% in 2021, then soared by 52bps to 0.18% in 2022, then increased by 7bps to 0.19% in 2023, then rose by 12bps to 0.21% in 2024, then fell by 0bps to 0.21% in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Return on Capital Employed are 0.21% (Q4 2025), 0.21% (Q3 2025), and 0.2% (Q2 2025).